Literature DB >> 23535091

Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms.

Enrique Gómez1, Natalia Blanca-Lopez, Maria Salas, Gabriela Canto, Paloma Campo, Maria J Torres, Cristobalina Mayorga, Miguel Blanca.   

Abstract

BACKGROUND: Although allergic drug reactions have been considered to be immediate (IgE mediated) or delayed (T-cell effector mechanisms), accelerated reactions have also been defined; however, they have not been sufficiently studied.
OBJECTIVE: To study the mechanisms involved in accelerated reactions to amoxicillin.
METHODS: We monitored the response in 3 patients who had an accelerated reaction to amoxicillin. A T-cell effector response was searched after a Drug Provocation Test. Symptoms were recorded after initiation of the reaction, and sequential samples were taken at different intervals after challenge. Skin biopsy specimens were also taken, and a lymphocyte transformation test (LTT) was performed.
RESULTS: After the drug provocation test, all 3 patients had a positive response within 2 to 6 hours of drug administration, with full expression at 6 hours, requiring corticoids and antihistamine treatment. They had generalized erythema with facial angioedema but no cardiovascular or respiratory symptoms. Monitoring of the response revealed the presence in the skin of CD4 and CD8 lymphocytes with increased expression of homing and cell activation markers. Immunohistochemistry revealed a perivascular mononuclear cell infiltrate with activated CD4 and CD8 cells expressing perforin and granzyme B. No tryptase release was detected in either the affected tissue or the peripheral blood. The LTT result was positive in all 3 patients.
CONCLUSION: We found that accelerated reactions to β-lactams are mediated by effector T cells. The increase in different T-cell markers and a positive LTT result to amoxicillin, in parallel with the occurrence of symptoms after challenge, support this mechanism.
Copyright © 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535091     DOI: 10.1016/j.anai.2013.01.003

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  4 in total

1.  Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

Authors:  Rannakoe J Lehloenya; Jonny G Peter; Ana Copascu; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10

2.  Converter Phenotype: A New Profile That Is Not Exclusive to Taxanes.

Authors:  Teodorikez Wilfox Jimenez-Rodriguez; Francisco Manuel Marco de la Calle; Inmaculada Lozano-Cubo; Rosa Ana Montoyo-Anton; Victor Soriano-Gomis; Purificación Gonzalez-Delgado; Amparo Burgos-San José; Seira Climent-Ballester; Natividad Martínez-Banaclocha; Javier Fernández-Sanchez
Journal:  Front Allergy       Date:  2022-01-12

3.  An unusual dual hypersensitivity reaction to moxifloxacin in a patient.

Authors:  Semra Demir; Derya Unal; Muge Olgac; Nilgun Akdeniz; Esin Aktas-Cetin; Asli Gelincik; Bahauddin Colakoglu; Suna Buyukozturk
Journal:  Asia Pac Allergy       Date:  2018-07-17

Review 4.  NSAID-induced reactions: classification, prevalence, impact, and management strategies.

Authors:  Natalia Blanca-Lopez; Victor Soriano; Elena Garcia-Martin; Gabriela Canto; Miguel Blanca
Journal:  J Asthma Allergy       Date:  2019-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.